Table 6: Table 6 displays the whether the listed strains of probiotic bacteria are resistant or susceptible to the following protein synthesis inhibiting antibiotics; Tetracycline (TET), Gentamycin (GEN), Kanamycin (KAN), Neomycin (NEO), Clindamycin (CLI), Chloramphenicol (CHL), Erythromycin (ERY), Mupirocin (MUP). (S = Sensitive |R = Resistance | N/A = Information not available | R/S = Bacteria has demonstrated resistance and susceptibility in studies) [130,131, 144, 146-148].
|
Protein Synthesis Inhibiting Antibiotics: |
||||||||
|
Bacteria; genus, species, strain |
TET |
GEN |
KAN |
NEO |
CLI |
CHL |
ERY |
MUP |
|
Bifidobacterium breve M-16V |
R |
R |
R |
R |
S |
S |
S |
S |
|
Propionibacterium acidipropionici |
S |
S |
R/S |
N/A |
N/A |
S |
S |
N/A |
|
Propionibacterium freudenreichii |
S |
S |
R/S |
N/A |
N/A |
S |
S |
N/A |
|
Propionibacterium jensenii |
S |
S |
R/S |
R |
N/A |
S |
S |
N/A |
|
Bacillus coagulans SZN1969 |
S |
S |
S |
S |
S |
S |
S |
S |
|
Bacillus subtilis DE111 |
S |
S |
S |
S |
S |
S |
S |
S |